Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures.

Volume: 17, Issue: 6, Pages: 1192 - 1200
Published: May 1, 2019
Abstract
Background & Aims null Platelet transfusion is used to prevent hemorrhagic events in patients with thrombocytopenia undergoing invasive procedures, but there are many disadvantages. We evaluated the efficacy and safety of lusutrombopag in patients with chronic liver disease and thrombocytopenia undergoing invasive procedures. null null null Methods null We performed a double-blind, parallel-group, phase 3 study of 96 patients with chronic liver...
Paper Details
Title
Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures.
Published Date
May 1, 2019
Volume
17
Issue
6
Pages
1192 - 1200
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.